TrialJournal of gastroenterology2021

Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study.

Yuki Tahata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.